It looks like the signal they found is intermittent aldosterone surges (especially during sleep). A single daytime blood test would miss this pattern.

He has done a lot for affordability with Cost Plus Drugs.

Also good for time-based deals (for example, happy hour specials) where businesses really do want to get more customers in the door at certain times.

Yes, rather than relying 100% on customers. Business will be better at updating correct cadence.

Broader awareness of mental health was good. But pathologizing every struggle weakens our capacity to confront hardship, grow, and flourish. I have to believe there's some better middle ground here.

For what it's worth, there's a separate Medicare program that caps out-of-pocket drug costs. Just launched this year. So I read this change as re-allocating budget rather than giving up on drug pricing.

True enough, but there are Alzheimer's drugs in development: https://www.sciencedaily.com/releases/2026/07/260711010118.h...

Interesting that they're starting with a screen less device. Is this because it's the right form factor, or just because it's easier to ship compared something that has a display, touch screen, etc?